By:
On:
In: Health, Human Interest
With: 0 Comments

The first infusion of an investigational drug that aims to delay or help to prevent the earliest memory loss due to Alzheimer’s disease took place in September at Butler Hospital in Providence, R.I., researchers announced.   Funded by the National Institutes of Health (NIH) and Eisai Inc., a US subsidiaryContinue Reading